慢性乙型肝炎患者生命质量影响因素分析  

Factors affecting quality of life in patients with chronic hepatitis B

作　　者：田长印[1] 张欣[1] 刘拉羊[1] 吕芳玲[1] 贾晓黎[1] 

机构地区：[1]西安交通大学医学院第二附属医院,陕西西安710004

出　　处：《中国感染控制杂志》2017年第2期156-159,共4页Chinese Journal of Infection Control

摘　　要：目的分析影响慢性乙型肝炎患者生命质量(QOL)的因素,为改善患者QOL提供参考。方法采用SF-36量表测量慢性乙型肝炎患者的QOL,Morisky量表测量患者的服药依从性,分析影响慢性乙型肝炎患者QOL的因素。结果 357例慢性乙型肝炎患者中,271例(75.91%)为已婚患者,107例(29.97%)有大专及以上学历,163例(45.66%)家庭人均月收入在2 000~5 000元,家庭成员中有患乙型肝炎者138例(38.66%),吸烟患者198例(55.46%),喝酒患者150例(42.02%)。慢性乙型肝炎患者服药依从性平均得分为(2.15±1.29)分。影响慢性乙型肝炎患者QOL的因素有患者年龄、受教育水平、患病时间、是否住院、是否饮酒和服药依从性6个方面,其中年龄、饮酒、乙型肝炎患病时间和既往住院史是影响慢性乙型肝炎患者QOL的消极因素,受教育水平和患者服药依从性是影响慢性乙型肝炎患者QOL的积极因素。结论加强慢性乙型肝炎患者对疾病的认识,提高其服药依从性,可以帮助患者改善QOL。ObjectiveTo analyze factors affecting quality of life（QOL） in patients with chronic hepatitis B（CHB）, and provide reference for improving QOL of patients. MethodsThe MOS 36item short form health survey （SF36） was adopted to survey QOL of patients with CHB, Morisky medication adherence scale was used to measure patients’ adherence to medication, factors affecting QOL of patients with CHB were analyzed. ResultsOf 357 CHB patients, 271（75.91%） were married, 107（29.97%） received college or above education, 163（45.66%） patients’ average household monthly income were ￥2 000-￥5 000, 138（38.66%）patients’ family members were also with CHB, 198 （55.46%） patients smoked, 150 （42.02%） drank. The average score of CHB patients’ adherence to medication was （2.15±1.29）. Factors affecting QOL in patients with CHB were age, education level, duration of disease, whether or not hospitalized, whether or not drink, as well as adherence to medication. Age, drink, and duration of hepatitis B, and previous hospitalization were negative factors affecting QOL in patients with CHB, education level and adherence to medication were positive factors affecting QOL in patients with CHB. ConclusionStrengthening CHB patients’ understanding on disease and improving their medication adherence can help them to improve QOL.

关 键 词：肝炎 乙型 慢性 生命质量 服药依从性 影响因素 

分 类 号：R512.62[医药卫生—内科学]